Chlorthalidone Reduces Cardiovascular Events Compared With Hydrochlorothiazide
- 1 April 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 57 (4) , 689-694
Abstract
There is significant controversy around whether chlorthalidone (CTD) is superior to hydrochlorothiazide (HCTZ) in hypertension management. The objective of this analysis was to evaluate the effects of CTD compared with HCTZ on cardiovascular event (CVE) rates. We performed a retrospective observational cohort study from the Multiple Risk Factor Intervention Trial data set from the National Heart, Lung, and Blood Institute. The Multiple Risk Factor Intervention Trial was a cardiovascular primary prevention trial where participants were men 35 to 57 years of age enrolled and followed beginning in 1973. CVEs were measured yearly, and time to event was assessed by Cox regression. Systolic blood pressure, total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglyceride, potassium, glucose, and uric acid were measured yearly. The difference between groups was evaluated by repeated-measures mixed modeling, and each model was adjusted for predictors of each variable. CVEs were significantly lower in those on CTD (adjusted hazard ratio: 0.51 [95% CI: 0.43 to 0.61]; P P P =0.0016). CTD displayed significantly lower SBP ( P P P =0.0009), lower potassium ( P =0.0003), and higher uric acid ( P <0.0001) over time compared with HCTZ. In conclusion, both HCTZ and CTD reduce CVEs compared with neither drug. When comparing both drugs, CTD reduces CVEs more than HCTZ, suggesting that CTD may be the preferred thiazide-type diuretic for hypertension in patients at high risk of CVEs.Keywords
This publication has 16 references indexed in Scilit:
- Meta-Analysis of Dose-Response Characteristics of Hydrochlorothiazide and Chlorthalidone: Effects on Systolic Blood Pressure and PotassiumAmerican Journal of Hypertension, 2010
- The Choice of Thiazide DiureticsHypertension, 2009
- The Role of Chlorthalidone in Patients With High‐Risk HypertensionThe Journal of Clinical Hypertension, 2009
- Chlorthalidone – a renaissance in use?Expert Opinion on Pharmacotherapy, 2009
- All Thiazide‐Like Diuretics Are Not Chlorthalidone: Putting the ACCOMPLISH Study Into PerspectiveThe Journal of Clinical Hypertension, 2009
- Comparative Antihypertensive Effects of Hydrochlorothiazide and Chlorthalidone on Ambulatory and Office Blood PressureHypertension, 2006
- Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension, 2003
- Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA, 2002
- MORTALITY AND MORBIDITY RESULTS FROM THE EUROPEAN WORKING PARTY ON HIGH BLOOD PRESSURE IN THE ELDERLY TRIAL*1, *2The Lancet, 1985
- Five-Year Findings of the Hypertension Detection and Follow-up ProgramJAMA, 1979